newsfilter
← Latest News
Business Wire·

BELLUS Health Reports Year 2022 Financial Results and Business Highlights

- Patient enrollment ongoing in the CALM Phase 3 program with topline data expected for CALM-1 in the second half of 2024 - - Ended year with US$337.1 million in cash, cash equivalents and short-term investments; cash